Accessibility Menu
 
Agenus logo

Agenus

(NASDAQ) AGEN

Current Price$3.69
Market Cap$142.46M
Since IPO (2000)-100%
5 Year-94%
1 Year+122%
1 Month+20%

Agenus Financials at a Glance

Market Cap

$142.46M

Revenue (TTM)

$114.20M

Net Income (TTM)

$115.00K

EPS (TTM)

$-0.39

P/E Ratio

-9.55

Dividend

$0.00

Beta (Volatility)

1.79 (High)

Price

$3.69

Volume

14,129

Open

$3.77

Previous Close

$3.69

Daily Range

$3.66 - $3.77

52-Week Range

$1.38 - $7.34

AGEN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Agenus

Industry

Biotechnology

Employees

81

CEO

Garo H. Armen, PhD

Headquarters

Lexington, MA 02421-7305, US

AGEN Financials

Key Financial Metrics (TTM)

Gross Margin

36%

Operating Margin

-18%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

21%

Return on Assets

0%

Earnings Yield

-10.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$142.46M

Shares Outstanding

38.40M

Volume

14.13K

Short Interest

0.00%

Avg. Volume

646.90K

Financials (TTM)

Gross Profit

$103.17M

Operating Income

$20.56M

EBITDA

$10.56M

Operating Cash Flow

$158.31M

Capital Expenditure

$576.00K

Free Cash Flow

$158.89M

Cash & ST Invst.

$3.00M

Total Debt

$334.90M

Agenus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$34.20M

+27.5%

Gross Profit

$33.61M

+576.3%

Gross Margin

98.25%

N/A

Market Cap

$142.46M

N/A

Market Cap/Employee

$450.82K

N/A

Employees

316

N/A

Net Income

$10.58M

+76.9%

EBITDA

$14.99M

+165.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$331.90M

-509.7%

Accounts Receivable

$1.83M

+349.9%

Inventory

$0.00

N/A

Long Term Debt

$179.78M

+111.5%

Short Term Debt

$155.11M

+1475.4%

Return on Assets

0.05%

N/A

Return on Invested Capital

20.86%

N/A

Free Cash Flow

$98.32M

-242.3%

Operating Cash Flow

$97.74M

-241.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FATEFate Therapeutics, Inc.
$1.10+1.85%
ABOSAcumen Pharmaceuticals, Inc.
$2.67-8.56%
HURATuHURA Biosciences, Inc.
$1.94+8.38%
TTRXTurn Therapeutics Inc.
$3.44+0.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
SMCISuper Micro Computer
$20.53-0.33%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About AGEN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.